CERS Cerus Corporation

2.290USD-2.14%Mkt Cap: 461.49M $P/E: —

Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The company offers INTERCEPT Blood System, a propriet…

Key Statistics

Company
Market Cap461.49M USD
Enterprise Value492.79M USD
Revenue (TTM)221.55M USD
Gross Profit112.29M USD
Net Income (TTM)-15.63M USD
Revenue/Share1.14 USD
Last Price2.290 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees261
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-468.00
PEG—
EV/EBITDA7466.58
EV/Revenue2.22
P/S2.13
P/B6.72
EPS (TTM)-0.03
EPS (Forward)-0.01
52W Range
1.38044% of range3.470
52W High3.470 USD
52W Low1.380 USD
Profitability
Gross Margin54.47%
Oper. Margin-3.23%
EBITDA Margin0.03%
Profit Margin-7.58%
ROE-24.33%
ROA-7.04%
Growth
Revenue Growth9.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF4.84M USD
CapEx (TTM)3.73M USD
FCF Margin0.40%
FCF Yield0.19%
Net Debt20.54M USD
Net Debt/EBITDA311.14
Balance Sheet
Debt/Equity1.51
Current Ratio1.83
Quick Ratio1.02
Book Value/Sh0.35 USD
Cash/Share0.28 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)5.125 USD
Upside (mean)+123.8%
Target Range4.000 USD – 6.500 USD
4.000+123.8% to mean6.500
# Analysts4
Ownership
Shares Out.201.52M
Float195.35M
Insiders3.61%
Institutions73.47%
Short Interest
Short Ratio12.4d
Short % Float9.19%
Short % Out.8.93%
Shares Short17.99M
Short (prev mo.)17.33M
Technical
SMA 502.579 (-11.2%)
SMA 2002.434 (-5.9%)
Beta1.83
S&P 52W Chg16.45%
Avg Vol (30d)1.71M
Avg Vol (10d)1.83M
Technical Indicators
RSI (14)36.4
MACD-0.0897
MACD Signal-0.0690
MACD Hist.-0.0207
BB Upper2.729 USD
BB Middle2.483 USD
BB Lower2.237 USD
BB Width19.78%
ATR (14)0.1137 USD
Vol Ratio (20d)0.50x